CORRELATION OF LIPID PROFILE WITH INTERLEUKIN-12 IN TYPE 2 DIABETES MELLITUS

Authors

  • Meri Ponda Sari Department of Clinical Pathology, Faculty of Medicine, Andalas University/Dr.M.Djamil Hospital Padang, Indonesia
  • Hanifah Maani Department of Clinical Pathology, Faculty of Medicine, Andalas University/Dr.M.Djamil Hospital Padang, Indonesia
  • Ellyza Nasrul Department of Clinical Pathology, Faculty of Medicine, Andalas University/Dr.M.Djamil Hospital Padang, Indonesia
  • Dia Rofinda

DOI:

https://doi.org/10.24293/ijcpml.v25i1.1486

Keywords:

Interleukin-12, lipid profile, type 2 diabetes mellitus

Abstract

Dyslipidemia is one of the common disorders in the diabetes mellitus (DM) patients causes cardiovascular disorders. Interleukin-12 (IL-12) is an important inflammation cytokine and elevated in type 2 DM (T2DM) which may contribute to inflammation of atherosclerotic plaque formation. Hyperglycemia, hyperlipidemia, hyperinsulinemia and oxidative stress that lead to endothelial dysfunction of atherosclerotic. The aim of this study to determine the correlation of lipid profile with IL-12 in T2DM. This study was an analytical study with cross-sectional design in 30 patients T2DM meet the inclusion and exclusion criteria and conduct blood tests at the Central Laboratory Installation of Dr. M. Djamil Hospital Padang in September 2016-August 2017. Level of lipid profile performed by the enzymatic colorimetric method. Sandwich ELISA used to measure the level of IL-12 in Biomedical Laboratory Medical Faculty of Andalas University. Spearman correlation was used, significant if p<0,05. The mean levels of total cholesterol, high-density lipoprotein, (HDL), triglycerides and low-density lipoprotein (LDL) in T2DM were  204.2 ± 42.8 mg/dL; 46.8 ± 9.3 mg/dL; 57 ± 53.4 mg/dL; 132.97 ± 41.0 mg/dL. The mean level of IL-12 in T2DM is 160.15 ± 99.05 pg/mL. Spearman correlation test of total cholesterol, (HDL), triglycerides and (LDL) with IL-12 are r= 0.228 (p=0.225); r= -0.234 (p=0.212); r= 0.415 (p=0.031); r= 0,215 (p=0.291) and analysis linear regression showed a moderate correlation between the levels triglycerides and Il-12 with r=0,512 and p<0,05. There is a moderate positive correlation between triglycerides, weak between total cholesterol and LDL with IL-12 and negative correlation between HDL with IL-12 in T2DM.

Downloads

Download data is not yet available.

References

Michael O, Ogunmola O, Tunji Y, Ayodeji K. Prevalence, variants and determinants of electrocardiographic abnormalities amongst elderly Nigerians with type 2 diabetes. Journal of Medicine and Medical Sciences. 2013; 4: 324-8.

Samatha P, Venkateswarlu M, Siva P. Lipid profile levels in type 2 diabetes mellitus from the tribal population of Adilabad in Andhra Pradesh, India. Journal of Clinical and Diagnostic Research. 2011; 6: 590-2.

Eltigani MA, Barri AM, Bakhel K, Ibrahim M, Abbas A, Mudri M, et al. Lipid profile abnormalities as predictive factor for electrocardiogram changes and coronary artery disease among Sudanese people in Shendi locality. International Invention Journal of Biochemistry. 2015; 3: 1-4.

Silva I, Almeida-Pititto B, Ferreira S. Reassessing lipid metabolism and its potentialities in the prediction of cardiovascular risk. Arch Endocrinal Metab.2015; 59: 171-80.

Mishra M, Kumar H, Bajpai S, Singh R, Tripathi K. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed T2DM. Diabetes Research and Clinical Practice, Elsevier. 2011; 1-7.

Wegner M, Winiarska H, Kozlowska T, Dworacka M. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. Cytokine, Elsevier. 2008: 312-6.

Bobry Y, Ivanova E, Chistiakov D, Nikiforov N, Orekhov A. Macrophages and their role in atherosclerosis: Pathophysiology and transcriptome analysis. Review article, Biomed Research International. 2016; 1-13.

Jelantik IGM, Haryati E. Relationship between ages, sex, obesity a hypertension with prevention of type 2 diabetes mellitus in Public Health of Mataram. JMBI. 2014; vol 8:1-6.

Powers AC. Diabetes mellitus. In: Harrison's principles of internal medicine, Ed 16., New York, McGraw-Hills Companies, 2005; 2152-79.

Mooradian A. Dyslipidemia in type 2 diabetes mellitus. Nature Reviews Endocrinology, 2009; 10: 150-9.

Miller M, Stone N, Ballantyne C, Bittner V, Criqui M, Ginsberg H, et al. Triglycerides and cardiovascular disease. A scientific statement from The American Heart Association. Circulation. 2011; 2292-333.

Packard R, Libby P. Inflammation in Atherosclerosis: From vascular biology to biomarker discovery and risk prediction. Review, Clinical Chemistry. 2008; 24-38.

Downloads

Submitted

2019-03-28

Accepted

2019-03-28

Published

2019-04-10

How to Cite

[1]
Sari, M.P., Maani, H., Nasrul, E. and Rofinda, D. 2019. CORRELATION OF LIPID PROFILE WITH INTERLEUKIN-12 IN TYPE 2 DIABETES MELLITUS. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 25, 1 (Apr. 2019), 31–34. DOI:https://doi.org/10.24293/ijcpml.v25i1.1486.

Issue

Section

Articles